Glaukos Corporation (NYSE:GKOS) Q4 2024 Earnings Conference Call
February 20, 2025 4:30 PM ET
Company Participants
Chris Lewis – Vice President, Investor Relations and Corporate Affairs
Tom Burns – Chairman and Chief Executive Officer
Joe Gilliam – President and Chief Operating Officer
Conference Call Participants
Tom Stephen – Stifel
Richard Newitter – Truist Securities
Allen Gong – JPMorgan
Michael Sarcone – Jefferies
Mason Carrico – Stephens
Anthony Petrone – Mizuho
Danielle Antalffy – UBS
Welcome to Glaukos Corporation’s Fourth Quarter and Full-Year 2024 Financial Results Conference Call. Copies of the company’s press release and quarterly summary document, both issued after the market closed today are available at the company’s website.
Impact on you:
Based on Glaukos Corporation’s Q4 2024 earnings conference call, investors in the company may want to pay attention to the financial results and any strategic announcements made during the call. This information can help guide investment decisions and potential future actions related to the company’s stock.
Impact on the world:
Glaukos Corporation’s financial results can have broader implications for the healthcare industry and medical technology sector. Positive earnings can indicate growth and innovation within the company, potentially leading to advancements in treatments for conditions such as glaucoma.
Conclusion:
In conclusion, Glaukos Corporation’s Q4 2024 earnings conference call provides valuable insights for investors and industry stakeholders alike. The information shared during the call can have important implications for both individual investors and the broader healthcare community.
